Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Borosil Scientific Ltd (BOROSCI)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544184 NSE: BOROSCI Glass | Small Cap | Borosil Scientific Share Price
₹117.90 -2.05 (-1.71%)
As on 23-Sep'26 16:59
Borosil Scientific Ltd (BOROSCI)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 544184 NSE: BOROSCI Glass | Small Cap | Borosil Scientific Share Price
₹117.90 -2.05 (-1.71%)
As on 23-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹1,049 Cr.
Current Price
₹117.9
52-Week Low / High
₹97 / 181
TTM EPS
₹4.9
TTM Sales
₹478 Cr.
Book Value per Share
₹48.6
P/E Ratio
24.30
Lower than its 5-year historical median
Industry PE
35.9
Price to Book (P/B)
2.43
Lower than its 5-year historical median
Price to Sales (P/S)
2.19
Lower than its 5-year historical median
EV/EBITDA
13.89
Lower than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
8.42%
In line with industry median
Return on Capital Employed (ROCE)
10.40%
Underperforms industry median
Return on Assets (ROA)
6.63%
Operating Profit Margin
12.1%
Net Profit Margin
7.4%
Gross Profit Margin
15.1%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
8.93%
Operating Profit Growth (1 Year)
-
6.29%
Net Profit Growth (1 Year)
-
29.42%
Asset Quality
Promoter Holding
68.27%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹423 Cr.
Equity
₹8.9 Cr.
Face Value
₹1
All Time Low / High
₹96.65 / 229.80
Check Before You Invest
Quality
Not GoodValuation
UndervaluedCheck Valuation charts
Price Trend
Weak
Is Borosil Scientific Ltd a good quality company?
Borosil Scientific Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Borosil Scientific Ltd performance compare with that of its Peers?
Revenue growth of Borosil Scientific Ltd vs industry peers?
Borosil Scientific Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Borosil Scientific Ltd?
Promoters hold 68.27% of the Borosil Scientific Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Borosil Scientific Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of -14.86% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Borosil Scientific Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|
| ROCE % ⓘ | 12.6% | 11.3% | 12.3% | 12.5% | - |
| Value Creation Index ⓘ | -0.1 | -0.2 | -0.1 | -0.1 | - |
Growth Parameters ⓘ |
|||||
| Sales ⓘ | 326 | 356 | 392 | 428 | 438 |
| Sales YoY Gr. | - | 9.4% | 10.1% | 8.9% | - |
| Adj EPS ⓘ | 103.1 | 3.5 | 3.9 | 5.1 | 5.2 |
| YoY Gr. | - | -96.6% | 11.3% | 30.3% | - |
| BVPS (₹) ⓘ | 1,162.1 | 41.9 | 46 | 50.4 | 51.2 |
| Adj Net Profit ⓘ | 29.5 | 31.4 | 35 | 45.6 | 46 |
| Cash Flow from Ops. ⓘ | -56.8 | 32.1 | 127 | 50.5 | - |
| Debt/CF from Ops. ⓘ | -0.2 | 0.3 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | NA | 9.5% | 8.9% | ||||
| Adj EPS ⓘ | NA | NA | -63.3% | 30.3% | ||||
| BVPSⓘ | NA | NA | -64.9% | 9.7% | ||||
| Share Price | - | - | - | -14.2% | ||||
Key Financial Parameters ⓘ
| Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|
| Return on Equity % ⓘ | 8.4 | 8.5 | 8.7 | 10.3 | 10.2 |
| Op. Profit Mgn % ⓘ | 15.6 | 14.7 | 14.9 | 16.5 | 16.5 |
| Net Profit Mgn % ⓘ | 9.1 | 8.8 | 8.9 | 10.7 | 10.5 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 0 | 257 | 207 | 161 | 118 |
| Cash Conv. Cycle ⓘ | 0 | 107 | 98 | 98 | 91 |
Valuation of Borosil Scientific - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Sales | 396 | 438 | 467 |
| Operating Expenses ⓘ + | 349 | 386 | 411 |
| Operating Profit ⓘ | 47 | 53 | 56 |
| Operating Profit Margin (%) | 11.8% | 12.0% | 12.0% |
| Other Income ⓘ + | 4 | 8 | 16 |
| Interest ⓘ | 3 | 2 | 1 |
| Depreciation ⓘ | 16 | 18 | 19 |
| Profit Before Tax ⓘ | 32 | 40 | 43 |
| Tax ⓘ | 8 | 14 | 8 |
| Profit After Tax | 23 | 27 | 35 |
| PAT Margin (%) | 5.9% | 6.1% | 7.4% |
| Adjusted EPS (₹) | 2.7 | 3.0 | 3.9 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 376 | 404 | 439 | ||||||||
| Debt + | 14 | 12 | 7 | ||||||||
| Minority Interest | 0 | 0 | 0 | ||||||||
| Trade Payables | 40 | 35 | 42 | ||||||||
| Others Liabilities ⓘ | 58 | 53 | 50 | ||||||||
| Total Liabilities ⓘ | 488 | 504 | 539 | ||||||||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 192 | 187 | 189 | ||||||||
| CWIP ⓘ | 1 | 1 | 9 | ||||||||
| Investments ⓘ | 0 | 105 | 122 | ||||||||
| Inventories | 97 | 97 | 103 | ||||||||
| Trade Receivables | 61 | 71 | 76 | ||||||||
| Cash Equivalents | 14 | 15 | 14 | ||||||||
| Others Assets ⓘ | 123 | 28 | 26 | ||||||||
| Total Assets ⓘ | 488 | 504 | 539 | ||||||||
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 30 | 120 | 43 |
| Cash Flow From Investing Activity ⓘ + | -2 | -115 | -37 |
| Cash Flow From Financing Activity ⓘ + | -16 | -3 | -6 |
| Net Cash Flow ⓘ | 12 | 1 | -0 |
| PARTICULARS | Mar'24 | Mar'25 | Mar'26 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 6.43 | 7.05 | 8.42 | |||||||
| ROCE (%) | 8.98 | 10.63 | 10.4 | |||||||
| Asset Turnover Ratio | 0.81 | 0.88 | 0.9 | |||||||
| PAT to CFO Conversion(x) | 1.3 | 4.44 | 1.23 | |||||||
| Working Capital Days | ||||||||||
| Receivable Days | 56.70 | 55 | 57.10 | |||||||
| Inventory Days | 89.30 | 80.50 | 78 | |||||||
| Payable Days | 101.70 | 84.90 | 84.60 | |||||||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Borosil Scientific Ltd FAQs
The current trading price of Borosil Scientific on 23-Sep-2026 16:59 is ₹117.9.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of Borosil Scientific stood at ₹1,048.7 Cr
The latest P/E ratio of Borosil Scientific as of 22-Sep-2026 is 22.74.
The latest P/B ratio of Borosil Scientific as of 22-Sep-2026 is 2.30.
The 52-week high of Borosil Scientific is ₹181.2 and the 52-week low is ₹96.65.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Borosil Scientific is ₹438 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Borosil Scientific Ltd is a below average quality company.
The key valuation ratios of Borosil Scientific Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Borosil Scientific Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Borosil Scientific Ltd
Borosil Scientific Limited was originally incorporated as a private limited company under the provisions of Companies Act, 1956 with the name and style of ‘Klass Pack Private Limited’ and certificate of incorporation dated May 29, 1991 was issued by Registrar of Companies, Mumbai. Subsequently, the Company was converted from a private limited company to a public limited company and consequently renamed as ‘Klass Pack Limited’ and a fresh certificate of incorporation dated June 19, 2018 was issued by the Registrar of Companies, Maharashtra at Mumbai. Pursuant to the Scheme of Arrangement, the name of the Company has been changed to Borosil Scientific Limited and a fresh certificate of incorporation dated December 05, 2023 was issued by the Registrar of Companies, Maharashtra at Mumbai.
Borosil Scientific is one of India's leading manufacturers of Glass Ampoules and Tubular Glass Vials of USP Type, widely used as primary packaging materials by pharmaceutical companies for their life-saving drugs. Its premium packaging materials ensure the utmost protection and preservation of vital medications, meeting the stringent standards set by the industry. The company has offered an entire gamut of the finest quality scientific and laboratory glassware, which finds application across varied disciplines such as Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology. From many years, the company has stood for reliability, accuracy, and dependability, and as a result, it has won the respect and steadfast allegiance of top pharmaceutical firms, R&D labs, and academic, medical, and scientific organizations.
The company controls the entire production process, ensuring high-quality standards and timely delivery of its products to meet customer demands. It has an unwavering commitment to excellence, implementing rigorous quality control measures at every stage to deliver products that meet the highest industry standards. It leverages technology to enhance operational efficiency, optimize processes, and improve customer experience. It prioritizes customer satisfaction by providing exceptional service and maintaining a robust supply chain. From order placement to after-sales support, its dedicated team ensures a seamless experience for its valued customers.
Business area of the company
The company offers an entire gamut of the finest quality scientific and laboratory glassware, which finds application across varied disciplines such as Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.
Products of the company
- Lab glassware
- Filtration products
- Analytical vials
- Lab accessories
- Laboratory equipment
- Glass ampoules
- Tubular glass vials
- Lab reactors
- Industrial reactors
- Lab rotary evaporator
- Industrial rotary evaporator
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
